Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study for Zoledronic Acid to Prevent High-Turnover Bone Loss After Bariatric Surgery

NCT03424239 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT03424239
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03424239 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study for Zoledronic Acid to Prevent High-Turnover Bone Loss After Bariatric Surgery
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Completed
Start date
August 1, 2018
Completion date
January 1, 2020
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bariatric surgery candidate